DROVELIS 3 mg/14.2 mg, film-coated tablets 72 tablets
Active ingredients: Drospirenone, Estetrol, Estetrol monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet72 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DROVELIS 3 mg/14,2 mg, comprimés pelliculés
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC aluminium de 72 comprimé(s) - plaquette(s) thermoformée(s) PVC aluminium de 12 comprimé(s)
- Marketing authorisation holder
- GEDEON RICHTER ( HONGRIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 14 Oct 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60689468CIP73023406CIP133400930234068Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DROSPIRÉNONEcomprimé actif rose | 3 mg · un comprimé | SA |
| ESTÉTROL MONOHYDRATÉcomprimé actif rose | — | SA |
| ESTÉTROLcomprimé actif rose | 14,2 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.